About
ACIST Medical Systems

About
ACIST Medical Systems

Based in Eden Prairie, Minnesota, ACIST Medical Systems, part of the Bracco Group, was founded by an interventional cardiologist on a mission.

Dr. Robert (Bob) F. Wilson, Professor of Medicine and Director of the Interventional Cardiology Program at the University of Minnesota, wanted to create a device that took into consideration the needs of both physicians and patients in the cath lab. This sparked the creation of ACIST CVi™, a device that simplifies contrast injection for all procedures.

Since then, ACIST has become a knowledge catalyst, helping interventional cardiologists quickly visualize, assess and improve patient treatment.

The Bracco Group

Bracco

Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,420 employees and annual total consolidated revenues of around 1,29 billion euros, 86% of which from international sales. The Bracco diagnostic imaging product portfolio is completed by medical devices and advanced imaging agents injection systems. 

Grant Request Form

To submit a grant request to ACIST Medical systems please fill out the Grant Request Form and submit to the ACIST Grants Team at grants@acist.com. All grant requests must be received 60 days prior to the date of the event or project due date.

Our mission

Through our relentless commitment to innovation, we optimize interventional decisions, equipping people with the power to get back to life. 

History

  • 1991

    Founded by Dr. Robert F. (Bob) Wilson.

  • 1997

    Receives FDA clearance to market the CL100H system, the first injection system for diagnostic and interventional cardiology. 

  • 2001

    Acquired by Milan-based Bracco Group, a world leader in the field of diagnostic imaging. 

  • 2005

    ACIST CVi™ Contrast Delivery System launches.

  • 2012

    ACIST acquires SVMI and the technology for ACIST HDi®.
  • 2014

    ACIST RXi® Rapid Exchange FFR System launches.

  • 2014

    ACIST HDi High-Definition IVUS System launches.
  • 2017

    ACIST RXi® Mini™ System launches.

  • 2017

    Brad Fox is appointed as ACIST President and CEO.
  • 2019

    HDi receives peripheral indication.

60+ countries

Products available in more than 60 countries

400+ employees

Employs 400+ people worldwide

Corporate citizenship

Here at ACIST we pride ourselves on being an active member in our local communities by giving back and supporting several nonprofits that help better society. We empower our team to champion efforts to improve the lives of others. 

Executive Team

Brad Fox

President, Chief Executive Officer

Ben Juen

Vice President, Sales Americas (CV)

Brian Lasiuk

Senior Vice President, Research & Development

Carl Bracken

Vice President, Quality Assurance

Jaimala Pai

Vice President, General Counsel & Secretary

Jay Johnson

Vice President, Cardiovascular Product Development

Jim Jennings

Vice President, Finance

Mark Kuehl

Vice President, Human Resources

Milana Solganik

Vice President, Regulatory & Clinical Affairs

Oliver Baumgartner

Director, EMEA Cardiovascular Commercial Operations

Tom Priebe

Vice President, Global Operations & Service

Locations

ACIST Corporate Headquarters

7905 Fuller Road
Eden Prairie, Minnesota 55344
Phone: 952-995-9300 or 888-667-6648
Fax: 952-941-4648 

ACIST Silicon Valley

6800 Koll Center Parkway,
Suite 180 Pleasanton, California 94566
Phone: 952-995-9300 or 888-667-6648

ACIST Europe B.V.

Argonstraat 3
6422 PH Heerlen
The Netherlands

Mailing address
PO Box 3050, 6401 DN Heerlen
Phone: +31 (0)45 750 7000
acistinfo@bracco.com 

ACIST Japan Inc.

7F Dainippon-Tosho Otsuka
3-Chrome Bldg. 3-11-6, Otsuka
Bunkyo-Ku, Tokyo 112-0012
Phone: +81 369029520 

See our specialties

ACIST can help with peripheral, cardiovascular disease and structural procedures. 

Interested in learning more?

Contact a rep to learn more about ACIST products. 

GENERAL CONDITIONS OF SALE

Skip to content